Who We Are
Medomie is an established privately owned pharmaceutical company, focused on distributing and selling of innovative, brand, biosimilar and niche generic products for patients in Israel and the Palestinian Authority.
As an innovative and ﬂexible pharmaceutical specialist, we are active in high-potential segments of the pharmaceutical market.
Our expertise lies in rapidly and efficiently identifying unexploited potential in known and unknown molecules and bringing them to market quickly.
We specialize in ﬁnding those speciﬁc molecules with added value both for our partners and the local markets.
We, at Medomie, are putting special emphasis on quality assurance, pharmacovigilance, and full compliance to GMP /GDP guidelines on import, storage and distribution in Israel and The Palestinian Authority.
What We Do
We aim to introduce even the smallest niche products and specialize in introducing unique generics, such as “old” molecules, difficult to get products and complex products. We want to become the market leader in unexploited medical needs by delivering one standard of excellence, one standard of quality, and one standard of service to every customer we serve.
Medomie is enthusiastic about performance and growth and intends to be in the top 5 pharmaceutical companies in our markets. Our passionate team is committed to becoming a leading pharmaceuticals player with a unique portfolio of essential high-quality, difficult-to-get niche products. We specialize in ﬁnding those speciﬁc molecules with added value both for our partners and the local markets. We believe that our ability to focus and ﬁnd speciﬁc molecules with extra value, will prove to be proﬁtable both for our partners and the local market.
360° Experience Throughout the Counter
Founder & CEO
A pharmacist with a track record of roles on the Public Health Sector, Reimbursement Committee, former deputy manager of the purchasing department of the second largest health organization in Israel, Head of New Technologies Committee, Head of Generics Tender Committee and more. All his experience is channeled today to fast forward our company to fulfill our vision.
Market Access Director
Dr. Dan Andrei Waitman
Medical Manager & BD Director
Dan is one of the most familiar faces in the pharmaceutical landscape of Israel from acting as MD in the ER in Sourasky Hospital to being the head of the Medical Dev. in Health funds and a constant member in the National Reimbursement Committee for the last 15 years.
Over 60 years combined experience
Medomie professional leadership team are client-oriented with a dynamic reactive approach to meet the needs of our partners and patients. Our ﬂexible structure enables us to make quick decisions, respond to changing conditions and bring medicines quickly to the market.